Use of repurposed and adjuvant drugs in hospital patients with covid-19: Multinational network cohort study

Albert Prats-Uribe, Anthony G. Sena, Lana Yin Hui Lai, Waheed Ul Rahman Ahmed, Heba Alghoul, Osaid Alser, Thamir M. Alshammari, Carlos Areia, William Carter, Paula Casajust, Dalia Dawoud, Asieh Golozar, Jitendra Jonnagaddala, Paras P. Mehta, Mengchun Gong, Daniel R. Morales, Fredrik Nyberg, Jose D. Posada, Martina Recalde, Elena RoelKarishma Shah, Nigam H. Shah, Lisa M. Schilling, Vignesh Subbian, David Vizcaya, Lin Zhang, Ying Zhang, Hong Zhu, Li Liu, Jaehyeong Cho, Kristine E. Lynch, Michael E. Matheny, Seng Chan You, Peter R. Rijnbeek, George Hripcsak, Jennifer C.E. Lane, Edward Burn, Christian Reich, Marc A. Suchard, Talita Duarte-Salles, Kristin Kostka, Patrick B. Ryan, Daniel Prieto-Alhambra

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Use of repurposed and adjuvant drugs in hospital patients with covid-19: Multinational network cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences